Scotland’s dermatology services are at a tipping point - only 68.9% of cancer patients treated within 62 days and a growing backlog. With proven, evidence-backed and regulated technologies already delivering impact in real-world skin cancer pathways, the issue isn’t whether the tools are ready - it’s the delay in adopting them. We’ll share impact and learnings from the use of DERM, AI as a medical device by Skin Analytics, across the NHS and how Scotland can use AI to move its dermatology services from scarcity to abundance.